AI Insights · Timothy · June 2024
Top 5 Final Fantasy Games on iOS in Netherlands Q2 2024
In Q2 2024, the top 5 Final Fantasy games on iOS in the Netherlands showcased varying trends in revenue, downloads, and active users. Sensor Tower provides more insights into these metrics.
The second quarter of 2024 saw interesting performance trends for the top 5 Final Fantasy games on the iOS platform in the Netherlands. Let's delve into the specifics of each game's metrics, based on data from Sensor Tower.
Final Fantasy XV: A New Empire by Epic Action LLC experienced notable fluctuations in revenue. Starting the quarter with approximately $2.7K, it peaked at around $4.2K by the end of April. However, a sharp decline followed, dipping to $545 in mid-May. Revenue rebounded in June, reaching near $4K in the week of June 17.
Final Fantasy XV: War for Eos from Machine Zone, Inc showed a more stable revenue trend, though at lower levels. Revenue began at $422 in early April, fluctuating slightly throughout the quarter, and peaked at $425 in mid-June.
FINAL FANTASY VII EVER CRISIS by SQUARE ENIX saw a varied revenue trend, starting at $595 in the first week of April and experiencing a mix of increases and decreases, finally landing at $123 by the end of June. Downloads were modest, peaking at 22 in mid-April, while weekly active users remained relatively stable, averaging around 200 throughout the quarter.
FINAL FANTASY BE:WOTV, also by SQUARE ENIX, had a more dynamic revenue performance. The game started with $404 in early April, spiking to $467 by the end of the month, and then fluctuating, reaching $349 in mid-June. Downloads were minimal, with only a few recorded sporadically.
FINAL FANTASY BRAVE EXVIUS, another title from SQUARE ENIX, showed a steady increase in revenue towards the end of the quarter. It started at $233 in early April and saw a significant rise, peaking at $498 in the last week of June. Downloads were very low, with only a few recorded instances.
For further insights and detailed analysis, visit Sensor Tower.